The LIFE Cooperative includes world-class companies - from SMEs to startups - in the Life Sciences and Health Cluster of the Northern Netherlands.
This invention involves a unique, inventive, and patented tablet formulation that allows STS to be administered orally in an effective and safe manner, enabling chronic treatment with STS. This has been demonstrated in vitro. The VFF plan represents the next step toward achieving proof of concept for STS as a treatment for CVDs through a clinical study in patients with Raynaud's syndrome.
